BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 1996;13:114-116. [PMID: 8673088 DOI: 10.1038/ng0596-114] [Cited by in Crossref: 436] [Cited by in F6Publishing: 348] [Article Influence: 17.4] [Reference Citation Analysis]
Number Citing Articles
1 Gammon A, Jasperson K, Kohlmann W, Burt RW. Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol 2009;23:219-31. [PMID: 19414148 DOI: 10.1016/j.bpg.2009.02.007] [Cited by in Crossref: 88] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
2 Bussaglia E, Pujol RM, Jesus Gil M, Martí RM, Tuneu A, Febrer MI, Garcia-patos V, Ruiz EM, Barnadas M, Alegre M, Serrano S, Matias-guiu X. PTEN Mutations in Eight Spanish Families and One Brazilian Family with Cowden Syndrome. Journal of Investigative Dermatology 2002;118:639-44. [DOI: 10.1046/j.1523-1747.2002.01728.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
3 Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Similarities of cutaneous and breast pathology in Cowden's Syndrome. Exp Dermatol 1998;7:380-90. [PMID: 9858141 DOI: 10.1111/j.1600-0625.1998.tb00338.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
4 Cappell MS. Pathophysiology, clinical presentation, and management of colon cancer. Gastroenterol Clin North Am. 2008;37:1-24, v. [PMID: 18313537 DOI: 10.1016/j.gtc.2007.12.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 63] [Article Influence: 6.4] [Reference Citation Analysis]
5 Syngal S, Bandipalliam P, Boland CR. Surveillance of patients at high risk for colorectal cancer. Medical Clinics of North America 2005;89:61-84. [DOI: 10.1016/j.mcna.2004.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
6 Wendt C, Margolin S. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer. Acta Oncol 2019;58:135-46. [PMID: 30606073 DOI: 10.1080/0284186X.2018.1529428] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 14.5] [Reference Citation Analysis]
7 Mester J, Eng C. Cowden syndrome: Recognizing and managing a not-so-rare hereditary cancer syndrome: Cowden Syndrome. J Surg Oncol 2015;111:125-30. [DOI: 10.1002/jso.23735] [Cited by in Crossref: 81] [Cited by in F6Publishing: 48] [Article Influence: 11.6] [Reference Citation Analysis]
8 Martín MG. The Biology of Inherited Disorders of the Gastrointestinal Tract Part I: Gastrointestinal Disorders: . Journal of Pediatric Gastroenterology & Nutrition 1998;26:321-35. [DOI: 10.1097/00005176-199803000-00016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ghoussaini M, Pharoah PD. Polygenic susceptibility to breast cancer: current state-of-the-art. Future Oncol 2009;5:689-701. [PMID: 19519208 DOI: 10.2217/fon.09.29] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
10 Newcomb PA, Wernli KJ. Risk Factors. In: Sauter ER, Daly MB, editors. Breast Cancer Risk Reduction and Early Detection. Boston: Springer US; 2010. pp. 3-22. [DOI: 10.1007/978-0-387-87583-5_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Sanson M. A Novel Germline Mutation of the PTEN/MMAC1 Gene in a Patient with Cowden Disease. Acta Oncologica 2009;38:973-5. [DOI: 10.1080/028418699432699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Weber F, Eng C. Update on the molecular diagnosis of endocrine tumors: toward -omics-based personalized healthcare? J Clin Endocrinol Metab 2008;93:1097-104. [PMID: 18390809 DOI: 10.1210/jc.2008-0212] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
13 Parsons R. Discovery of the PTEN Tumor Suppressor and Its Connection to the PI3K and AKT Oncogenes. Cold Spring Harb Perspect Med 2020;10:a036129. [PMID: 31932465 DOI: 10.1101/cshperspect.a036129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Yehia L, Niazi F, Ni Y, Ngeow J, Sankunny M, Liu Z, Wei W, Mester JL, Keri RA, Zhang B, Eng C. Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer. Am J Hum Genet 2015;97:661-76. [PMID: 26522472 DOI: 10.1016/j.ajhg.2015.10.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 8.7] [Reference Citation Analysis]
15 Harach HR, Soubeyran I, Brown A, Bonneau D, Longy M. Thyroid pathologic findings in patients with Cowden disease. Annals of Diagnostic Pathology 1999;3:331-40. [DOI: 10.1016/s1092-9134(99)80011-2] [Cited by in Crossref: 97] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
16 Stadler ZK, Robson ME. Inherited predisposition to endometrial cancer: Moving beyond Lynch syndrome: Inherited Predisposition to Endometrial Cancer. Cancer 2015;121:644-7. [DOI: 10.1002/cncr.29107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
17 Woodford-Richens K, Bevan S, Churchman M, Dowling B, Jones D, Norbury CG, Hodgson SV, Desai D, Neale K, Phillips RK, Young J, Leggett B, Dunlop M, Rozen P, Eng C, Markie D, Rodriguez-Bigas MA, Sheridan E, Iwama T, Eccles D, Smith GT, Kim JC, Kim KM, Sampson JR, Evans G, Tejpar S, Bodmer WF, Tomlinson IP, Houlston RS. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut. 2000;46:656-660. [PMID: 10764709 DOI: 10.1136/gut.46.5.656] [Cited by in Crossref: 87] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
18 Mangas C, Hilari JM, Ribera M, Robledo M, Urioste M, Benítez J, Fuente MJ, Ferrándiz C. Cowden disease in a family: A clinical and genetic diagnosis. Journal of the American Academy of Dermatology 2005;53:359-60. [DOI: 10.1016/j.jaad.2005.03.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Britton S, Freeman T, Vafiadaki E, Keers S, Harrison R, Bushby K, Bashir R. The third human FER-1-like protein is highly similar to dysferlin. Genomics 2000;68:313-21. [PMID: 10995573 DOI: 10.1006/geno.2000.6290] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 2.4] [Reference Citation Analysis]
20 Vasovčák P, Senkeříková M, Hatlová J, Křepelová A. Multiple primary malignancies and subtle mucocutaneous lesions associated with a novel PTEN gene mutation in a patient with Cowden syndrome: case report. BMC Med Genet 2011;12:38. [PMID: 21406108 DOI: 10.1186/1471-2350-12-38] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
21 Ehst BD, Minzer-Conzetti K, Swerdlin A, Devere TS. Cutaneous manifestations of internal malignancy. Curr Probl Surg 2010;47:384-445. [PMID: 20363406 DOI: 10.1067/j.cpsurg.2010.01.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
22 Feilotter HE, Coulon V, McVeigh JL, Boag AH, Dorion-Bonnet F, Duboué B, Latham WC, Eng C, Mulligan LM, Longy M. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Br J Cancer 1999;79:718-23. [PMID: 10070859 DOI: 10.1038/sj.bjc.6690115] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 3.4] [Reference Citation Analysis]
23 Bennett KL, Mester J, Eng C. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA 2010;304:2724-31. [PMID: 21177507 DOI: 10.1001/jama.2010.1877] [Cited by in Crossref: 109] [Cited by in F6Publishing: 90] [Article Influence: 9.9] [Reference Citation Analysis]
24 van der Groep P, van der Wall E, van Diest PJ. Pathology of hereditary breast cancer. Cell Oncol (Dordr). 2011;34:71-88. [PMID: 21336636 DOI: 10.1007/s13402-011-0010-3] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 8.0] [Reference Citation Analysis]
25 Yakubov E, Ghoochani A, Buslei R, Buchfelder M, Eyüpoglu IY, Savaskan N. Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency. Oncoscience 2016;3:149-55. [PMID: 27489861 DOI: 10.18632/oncoscience.305] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
26 Baba M, Schmidt LS, Linehan WM. Hereditary Renal Cell Carcinoma. In: Oya M, editor. Renal Cell Carcinoma. Tokyo: Springer Japan; 2017. pp. 19-82. [DOI: 10.1007/978-4-431-55531-5_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Ni Y, He X, Chen J, Moline J, Mester J, Orloff MS, Ringel MD, Eng C. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum Mol Genet 2012;21:300-10. [PMID: 21979946 DOI: 10.1093/hmg/ddr459] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
28 Wirtzfeld DA, Petrelli NJ, Rodriguez-Bigas MA. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol. 2001;8:319-327. [PMID: 11352305 DOI: 10.1007/s10434-001-0319-7] [Cited by in Crossref: 114] [Cited by in F6Publishing: 74] [Article Influence: 5.7] [Reference Citation Analysis]
29 Maraghelli D, Giusti F, Marini F, Brandi ML. Bone tissue and mineral metabolism in hereditary endocrine tumors: clinical manifestations and genetic bases. Orphanet J Rare Dis 2020;15:102. [PMID: 32326947 DOI: 10.1186/s13023-020-01380-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
30 Shah KR, Boland CR, Patel M, Thrash B, Menter A. Cutaneous manifestations of gastrointestinal disease. Journal of the American Academy of Dermatology 2013;68:189.e1-189.e21. [DOI: 10.1016/j.jaad.2012.10.037] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
31 Manning-Geist BL, Gatius S, Liu Y, Gil M, Da Cruz Paula A, Tuset N, Abu-Rustum NR, Aghajanian C, Weigelt B, Matias-Guiu X. Diagnosis and management of an endometrial cancer patient with Cowden syndrome. Gynecol Oncol 2021;163:14-21. [PMID: 34446268 DOI: 10.1016/j.ygyno.2021.08.008] [Reference Citation Analysis]
32 Trivedi MS, Crew KD. Implications of multigene testing for hereditary breast cancer in primary care. World J Obstet Gynecol 2016; 5(1): 50-57 [DOI: 10.5317/wjog.v5.i1.50] [Reference Citation Analysis]
33 Macharia LW, Wanjiru CM, Mureithi MW, Pereira CM, Ferrer VP, Moura-Neto V. MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness. Front Genet. 2019;10:125. [PMID: 30842790 DOI: 10.3389/fgene.2019.00125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
34 Stratton MR. Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 1996;5 Spec No:1515-9. [PMID: 8875258 DOI: 10.1093/hmg/5.supplement_1.1515] [Cited by in Crossref: 43] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
35 Agrawal S, Eng C. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Human Molecular Genetics 2006;15:777-87. [DOI: 10.1093/hmg/ddi492] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
36 Leão JC, Batista V, Guimarães PB, Belo J, Porter SR. Cowden's syndrome affecting the mouth, gastrointestinal, and central nervous system: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:569-572. [PMID: 15829879 DOI: 10.1016/j.tripleo.2004.08.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
37 Shepherd N. Polyps and polyposis syndromes of the intestines. Current Diagnostic Pathology 1997;4:222-38. [DOI: 10.1016/s0968-6053(05)80065-1] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
38 Guillem JG, Smith AJ, Calle JP, Ruo L. Gastrointestinal polyposis syndromes. Curr Probl Surg 1999;36:217-323. [PMID: 10212621 DOI: 10.1016/s0011-3840(99)80013-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
39 van Marcke C, De Leener A, Berlière M, Vikkula M, Duhoux FP. Routine use of gene panel testing in hereditary breast cancer should be performed with caution. Crit Rev Oncol Hematol 2016;108:33-9. [PMID: 27931838 DOI: 10.1016/j.critrevonc.2016.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
40 Huang SC, Erdman SH. Pediatric juvenile polyposis syndromes: An update. Curr Gastroenterol Rep 2009;11:211-9. [DOI: 10.1007/s11894-009-0033-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
41 van Orsouw NJ, Dhanda RK, Elhaji Y, Narod SA, Li FP, Eng C, Vijg J. A highly accurate, low cost test for BRCA1 mutations. J Med Genet 1999;36:747-53. [PMID: 10528853 DOI: 10.1136/jmg.36.10.747] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
42 Bruni P, Boccia A, Baldassarre G, Trapasso F, Santoro M, Chiappetta G, Fusco A, Viglietto G. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Oncogene 2000;19:3146-55. [PMID: 10918569 DOI: 10.1038/sj.onc.1203633] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 4.9] [Reference Citation Analysis]
43 Doxey BW, Kuwada SK, Burt RW. Inherited Polyposis Syndromes: Molecular Mechanisms, Clinicopathology, and Genetic Testing. Clinical Gastroenterology and Hepatology 2005;3:633-41. [DOI: 10.1016/s1542-3565(05)00370-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
44 Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223-62; quiz 263. [PMID: 25645574 DOI: 10.1038/ajg.2014.435] [Cited by in Crossref: 735] [Cited by in F6Publishing: 536] [Article Influence: 122.5] [Reference Citation Analysis]
45 Trojan J, Plotz G, Brieger A, Raedle J, Meltzer SJ, Wolter M, Zeuzem S. Activation of a cryptic splice site of PTEN and loss of heterozygosity in benign skin lesions in Cowden disease. J Invest Dermatol 2001;117:1650-3. [PMID: 11886535 DOI: 10.1046/j.0022-202x.2001.01954.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
46 Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA, Milas K, Pederson H, Remzi B, Orloff MS, Eng C. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 2011;88:42-56. [PMID: 21194675 DOI: 10.1016/j.ajhg.2010.11.013] [Cited by in Crossref: 240] [Cited by in F6Publishing: 191] [Article Influence: 21.8] [Reference Citation Analysis]
47 Antoniou AC, Easton DF. Models of genetic susceptibility to breast cancer. Oncogene 2006;25:5898-905. [PMID: 16998504 DOI: 10.1038/sj.onc.1209879] [Cited by in Crossref: 170] [Cited by in F6Publishing: 147] [Article Influence: 11.3] [Reference Citation Analysis]
48 Lodish MB, Stratakis CA. The differential diagnosis of familial lentiginosis syndromes. Fam Cancer 2011;10:481-90. [PMID: 21538076 DOI: 10.1007/s10689-011-9446-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
49 Darbro BW, Singh R, Zimmerman MB, Mahajan VB, Bassuk AG. Autism Linked to Increased Oncogene Mutations but Decreased Cancer Rate. PLoS One 2016;11:e0149041. [PMID: 26934580 DOI: 10.1371/journal.pone.0149041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
50 He X, Ni Y, Wang Y, Romigh T, Eng C. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53. Hum Mol Genet 2011;20:80-9. [PMID: 20926450 DOI: 10.1093/hmg/ddq434] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
51 Ponti G, Pellacani G, Seidenari S, Pollio A, Muscatello U, Tomasi A. Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. Critical Reviews in Oncology/Hematology 2013;85:239-56. [DOI: 10.1016/j.critrevonc.2012.07.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
52 Stratakis CA, Kirschner LS, Taymans SE, Tomlinson IPM, Marsh DJ, Torpy DJ, Giatzakis C, Eccles DM, Theaker J, Houlston RS, Blouin J, Antonarakis SE, Basson CT, Eng C, Carney JA. Carney Complex, Peutz-Jeghers Syndrome, Cowden Disease, and Bannayan-Zonana Syndrome Share Cutaneous and Endocrine Manifestations, But Not Genetic Loci. The Journal of Clinical Endocrinology & Metabolism 1998;83:2972-6. [DOI: 10.1210/jcem.83.8.5042] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
53 Garg K, Karnezis AN, Rabban JT. Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation. Pathology 2018;50:238-56. [PMID: 29373116 DOI: 10.1016/j.pathol.2017.10.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
54 Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007;44:579-85. [PMID: 17526800 DOI: 10.1136/jmg.2007.049981] [Cited by in Crossref: 123] [Cited by in F6Publishing: 87] [Article Influence: 8.8] [Reference Citation Analysis]
55 Calonje E, Brenn T, Lazar A. Tumors of the hair follicle. McKee's Pathology of the Skin. Elsevier; 2012. pp. 1445-87. [DOI: 10.1016/b978-1-4160-5649-2.00031-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Eng C. From bench to bedside... but when? Genome Res 1997;7:669-72. [PMID: 9253596 DOI: 10.1101/gr.7.7.669] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
57 Jass JR. Colorectal polyposes: from phenotype to diagnosis. Pathol Res Pract. 2008;204:431-447. [PMID: 18541388 DOI: 10.1016/j.prp.2008.03.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
58 Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
59 Jornayvaz FR, Philippe J. Mucocutaneous papillomatous papules in Cowden’s syndrome. Clin Exp Dermatol 2008;33:151-3. [DOI: 10.1111/j.1365-2230.2007.02602.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
60 Vega A, Torres J, Torres M, Cameselle-Teijeiro J, Macia M, Carracedo A, Pulido R. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease. J Invest Dermatol. 2003;121:1356-1359. [PMID: 14675182 DOI: 10.1111/j.1523-1747.2003.12638.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
61 Mazereeuw-hautier J, Assouere M, Moreau-cabarrot A, Longy M, Bonafe J. Cowden's syndrome: possible association with testicular seminoma. Br J Dermatol 2004;150:378-9. [DOI: 10.1111/j.1365-2133.2003.05770.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
62 Pilarski R, Nagy R. Genetic Testing by Cancer Site: Endocrine System. The Cancer Journal 2012;18:364-71. [DOI: 10.1097/ppo.0b013e3182609458] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
63 Negoro K, Takahashi S, Kinouchi Y, Takagi S, Hiwatashi N, Ichinohasama R, Shimosegawa T, Toyota T. Analysis of the PTEN gene mutation in polyposis syndromes and sporadic gastrointestinal tumors in Japanese patients. Diseases of the Colon & Rectum 2000;43:S29-33. [DOI: 10.1007/bf02237223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
64 Simpson L, Parsons R. PTEN: life as a tumor suppressor. Exp Cell Res 2001;264:29-41. [PMID: 11237521 DOI: 10.1006/excr.2000.5130] [Cited by in Crossref: 435] [Cited by in F6Publishing: 411] [Article Influence: 21.8] [Reference Citation Analysis]
65 Prabhu SS, Aldape KD, Bruner JM, Weinberg JS, Weinberg JS. Cowden Disease with Lhermitte-Duclos Disease: Case Report. Can j neurol sci 2004;31:542-9. [DOI: 10.1017/s0317167100003784] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
66 Ngeow J, Sesock K, Eng C. Clinical Implications for Germline PTEN Spectrum Disorders. Endocrinol Metab Clin North Am. 2017;46:503-517. [PMID: 28476234 DOI: 10.1016/j.ecl.2017.01.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
67 Heaney RM, Farrell M, Stokes M, Gorey T, Murray D. Cowden Syndrome: Serendipitous Diagnosis in Patients with Significant Breast Disease. Case Series and Literature Review. Breast J 2017;23:90-4. [PMID: 27886412 DOI: 10.1111/tbj.12691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
68 Olschwang S, Serova-sinilnikova OM, Lenoir GM. PTEN germ-line mutations in juvenile polyposis coli. Nat Genet 1998;18:12-4. [DOI: 10.1038/ng0198-12] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 4.4] [Reference Citation Analysis]
69 Vasovcak P, Krepelova A, Puchmajerova A, Spicak J, Voska L, Musilova A, Mestak J, Martinek J. A novel mutation of PTEN gene in a patient with Cowden syndrome with excessive papillomatosis of the lips, discrete cutaneous lesions, and gastrointestinal polyposis: . European Journal of Gastroenterology & Hepatology 2007;19:513-7. [DOI: 10.1097/meg.0b013e3280d6ed4b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
70 Banno K, Nogami Y, Kisu I, Yanokura M, Umene K, Masuda K, Kobayashi Y, Yamagami W, Susumu N, Aoki D. Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer. Int J Mol Sci 2013;14:12123-37. [PMID: 23743825 DOI: 10.3390/ijms140612123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
71 Abbas A, Padmanabhan R, Romigh T, Eng C. PTEN modulates gene transcription by redistributing genome-wide RNA polymerase II occupancy. Hum Mol Genet 2019;28:2826-34. [PMID: 31127935 DOI: 10.1093/hmg/ddz112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
72 Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G. Hereditary ovarian cancer. Crit Rev Oncol Hematol 2009;69:28-44. [PMID: 18656380 DOI: 10.1016/j.critrevonc.2008.06.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 5.2] [Reference Citation Analysis]
73 Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 2008;27:5387-97. [PMID: 18794875 DOI: 10.1038/onc.2008.237] [Cited by in Crossref: 97] [Cited by in F6Publishing: 74] [Article Influence: 7.5] [Reference Citation Analysis]
74 Laury AR, Bongiovanni M, Tille J, Kozakewich H, Nosé V. Thyroid Pathology in PTEN -Hamartoma Tumor Syndrome: Characteristic Findings of a Distinct Entity. Thyroid 2011;21:135-44. [DOI: 10.1089/thy.2010.0226] [Cited by in Crossref: 62] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
75 Ball MW, Shuch BM. Inherited kidney cancer syndromes. Curr Opin Urol 2019;29:334-43. [PMID: 31083011 DOI: 10.1097/MOU.0000000000000646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
76 Lv XP. Gastrointestinal tract cancers: Genetics, heritability and germ line mutations. Oncol Lett 2017;13:1499-508. [PMID: 28454282 DOI: 10.3892/ol.2017.5629] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
77 Koch R, Scholz M, Nelen MR, Schwechheimer K, Epplen JT, Harders AG. Lhermitte-Duclos disease as a component of Cowden's syndrome. Case report and review of the literature. J Neurosurg 1999;90:776-9. [PMID: 10193626 DOI: 10.3171/jns.1999.90.4.0776] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
78 Takei H, Dauser R, Su J, Chintagumpala M, Bhattacharjee MB, Jones J, Adesina AM. Anaplastic ganglioglioma arising from a Lhermitte-Duclos-like lesion. Case report. J Neurosurg 2007;107:137-42. [PMID: 18459885 DOI: 10.3171/PED-07/08/137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
79 Atta IS, AlQahtani FN. Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence. Case Rep Med 2016;2016:2928084. [PMID: 27087812 DOI: 10.1155/2016/2928084] [Reference Citation Analysis]
80 Nagy R, Ganapathi S, Comeras I, Peterson C, Orloff M, Porter K, Eng C, Ringel MD, Kloos RT. Frequency of germline PTEN mutations in differentiated thyroid cancer. Thyroid 2011;21:505-10. [PMID: 21417916 DOI: 10.1089/thy.2010.0365] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
81 Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet. 2002;70:829-844. [PMID: 11875759 DOI: 10.1086/340026] [Cited by in Crossref: 313] [Cited by in F6Publishing: 269] [Article Influence: 16.5] [Reference Citation Analysis]
82 Yehia L, Eng C. 65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine. Endocrine-Related Cancer 2018;25:T121-40. [DOI: 10.1530/erc-18-0162] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
83 Gage M, Wattendorf D, Henry LR. Translational advances regarding hereditary breast cancer syndromes. J Surg Oncol 2012;105:444-51. [PMID: 22441895 DOI: 10.1002/jso.21856] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
84 Horvath A, Stratakis CA. Carney complex and lentiginosis. Pigment Cell Melanoma Res 2009;22:580-7. [PMID: 19650827 DOI: 10.1111/j.1755-148X.2009.00613.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
85 Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria. JNCI Journal of the National Cancer Institute 2013;105:1607-16. [DOI: 10.1093/jnci/djt277] [Cited by in Crossref: 285] [Cited by in F6Publishing: 189] [Article Influence: 35.6] [Reference Citation Analysis]
86 Gronwald J, Byrski T, Huzarski T, Oszurek O, Janicka A, Szymanska-Pasternak J, Górski B, Menkiszak J, Rzepka-Górska I, Lubinski J. Hereditary breast and ovarian cancer. Hered Cancer Clin Pract 2008;6:88-98. [PMID: 19804604 DOI: 10.1186/1897-4287-6-2-88] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
87 Melbārde-Gorkuša I, Irmejs A, Bērziņa D, Strumfa I, Aboliņš A, Gardovskis A, Subatniece S, Trofimovičs G, Gardovskis J, Miklaševičs E. Challenges in the management of a patient with Cowden syndrome: case report and literature review. Hered Cancer Clin Pract 2012;10:5. [PMID: 22503188 DOI: 10.1186/1897-4287-10-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
88 Edelstein S, Naidich TP, Newton TH. The Rare Phakomatoses. Pediatric Neuroradiology. Berlin: Springer Berlin Heidelberg; 2005. pp. 819-54. [DOI: 10.1007/3-540-26398-5_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
89 Marsh DJ, Dahia PL, Caron S, Kum JB, Frayling IM, Tomlinson IP, Hughes KS, Eeles RA, Hodgson SV, Murday VA. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet. 1998;35:881-885. [PMID: 9832031 DOI: 10.1136/jmg.35.11.881] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
90 Bertagnolli MM. Surgical Prevention of Cancer. JCO 2005;23:324-32. [DOI: 10.1200/jco.2005.08.096] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
91 Pilarski R. PTEN Hamartoma Tumor Syndrome: A Clinical Overview. Cancers (Basel) 2019;11:E844. [PMID: 31216739 DOI: 10.3390/cancers11060844] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 19.5] [Reference Citation Analysis]
92 Chung SH, Woldenberg N, Roth AR, Masamed R, Conlon W, Cohen JG, Joines MM, Patel MK. BRCA and Beyond: Comprehensive Image-rich Review of Hereditary Breast and Gynecologic Cancer Syndromes. RadioGraphics 2020;40:306-25. [DOI: 10.1148/rg.2020190084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
93 Abel TW, Baker SJ, Fraser MM, Tihan T, Nelson JS, Yachnis AT, Bouffard JP, Mena H, Burger PC, Eberhart CG. Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 2005;64:341-9. [PMID: 15835270 DOI: 10.1093/jnen/64.4.341] [Cited by in Crossref: 73] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
94 Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 2001;21:1-18. [PMID: 11443730 DOI: 10.1002/gepi.1014] [Cited by in Crossref: 192] [Cited by in F6Publishing: 160] [Article Influence: 9.6] [Reference Citation Analysis]
95 Lobo GP, Waite KA, Planchon SM, Romigh T, Houghton JA, Eng C. ATP modulates PTEN subcellular localization in multiple cancer cell lines. Human Molecular Genetics 2008;17:2877-85. [DOI: 10.1093/hmg/ddn185] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
96 Vantomme N, Van Calenbergh F, Goffin J, Sciot R, Demaerel P, Plets C. Lhermitte–Duclos disease is a clinical manifestation of Cowden’s syndrome. Surgical Neurology 2001;56:201-4. [DOI: 10.1016/s0090-3019(01)00552-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
97 Dahdaleh FS, Carr JC, Calva D, Howe JR. Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23. Clin Genet. 2012;81:110-116. [PMID: 21834858 DOI: 10.1111/j.1399-0004.2011.01763.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
98 Cappell MS. From Colonic Polyps to Colon Cancer: Pathophysiology, Clinical Presentation, and Diagnosis. Clinics in Laboratory Medicine 2005;25:135-77. [DOI: 10.1016/j.cll.2004.12.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
99 Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics 2010;5:491-8. [PMID: 20543579 DOI: 10.4161/epi.5.6.12431] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
100 Sadahiro H, Ishihara H, Goto H, Oka F, Shirao S, Yoneda H, Suzuki M. Postoperative dural arteriovenous fistula in a patient with Cowden disease: a case report. J Stroke Cerebrovasc Dis 2014;23:572-5. [PMID: 23680687 DOI: 10.1016/j.jstrokecerebrovasdis.2013.04.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
101 Sardinoux M, Raingeard I, Bessis D, Coupier I, Renard E, Bringer J. Le syndrome de Cowden ou syndrome des hamartomes multiples en endocrinologie clinique. Annales d'Endocrinologie 2010;71:264-73. [DOI: 10.1016/j.ando.2010.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
102 Fountzilas C, Kaklamani VG. Multi-gene Panel Testing in Breast Cancer Management. Cancer Treat Res 2018;173:121-40. [PMID: 29349761 DOI: 10.1007/978-3-319-70197-4_8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
103 Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang WL, Lazar AJ. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors. J Cutan Pathol 2012;39:493-9. [PMID: 22486434 DOI: 10.1111/j.1600-0560.2012.01888.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
104 Jass JR. Gastrointestinal Polyposes: Clinical, Pathological and Molecular Features. Gastroenterology Clinics of North America 2007;36:927-46. [DOI: 10.1016/j.gtc.2007.08.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
105 Narod SA. Hereditary breast carcinoma syndromes. Cancer 1997;80:537-42. [DOI: 10.1002/(sici)1097-0142(19970801)80:3+<537::aid-cncr3>3.0.co;2-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
106 Pezzolesi MG, Platzer P, Waite KA, Eng C. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am J Hum Genet. 2008;82:1141-1149. [PMID: 18460397 DOI: 10.1016/j.ajhg.2008.04.005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
107 Patini R, Staderini E, Gallenzi P. Multidisciplinary surgical management of Cowden syndrome: Report of a case. J Clin Exp Dent 2016;8:e472-4. [PMID: 27703620 DOI: 10.4317/jced.52919] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
108 Marsh DJ, Dahia PLM, Coulon V, Zheng Z, Dorion-bonnet F, Call KM, Little R, Lin AY, Eeles RA, Goldstein AM, Hodgson SV, Richardson A, Robinson BG, Weber HC, Longy M, Eng C. Allelic imbalance, including deletion ofPTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with cowden syndrome and germlinePTEN mutation. Genes Chromosom Cancer 1998;21:61-9. [DOI: 10.1002/(sici)1098-2264(199801)21:1<61::aid-gcc8>3.0.co;2-6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
109 Heikkinen T, Greco D, Pelttari LM, Tommiska J, Vahteristo P, Heikkilä P, Blomqvist C, Aittomäki K, Nevanlinna H. Variants on the promoter region of PTEN affect breast cancer progression and patient survival. Breast Cancer Res 2011;13:R130. [PMID: 22171747 DOI: 10.1186/bcr3076] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
110 Nguyen KA, Syed JS, Shuch B. Hereditary Kidney Cancer Syndromes and Surgical Management of the Small Renal Mass. Urol Clin North Am 2017;44:155-67. [PMID: 28411908 DOI: 10.1016/j.ucl.2016.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
111 Gaur S, Turkbey B, Choyke P. Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management. Semin Ultrasound CT MR 2017;38:59-71. [PMID: 28237281 DOI: 10.1053/j.sult.2016.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
112 Henderson CJ, Ngeow J, Collins MH, Martin LJ, Putnam PE, Abonia JP, Marsolo K, Eng C, Rothenberg ME. Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes. J Pediatr Gastroenterol Nutr 2014;58:553-60. [PMID: 24345843 DOI: 10.1097/MPG.0000000000000253] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
113 Eng C. Cowden Syndrome. J Genet Counsel 1997;6:181-92. [DOI: 10.1023/a:1025664119494] [Cited by in Crossref: 81] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
114 Merg A, Howe JR. Genetic conditions associated with intestinal juvenile polyps. Am J Med Genet 2004;129C:44-55. [DOI: 10.1002/ajmg.c.30020] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
115 Rich TA, Woodson AH, Litton J, Arun B. Hereditary breast cancer syndromes and genetic testing: Breast Cancer Syndromes and Genetic Testing. J Surg Oncol 2015;111:66-80. [DOI: 10.1002/jso.23791] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
116 Webber LP, Martins MD, Carrard VC, Trevizani Martins MA, Munerato MC. Cowden syndrome-a case report emphasizing the role of the dental surgeon in diagnosis: COWDEN SYNDROME DIAGNOSED FOR DENTAL SURGEON. Spec Care Dentist 2015;35:51-4. [DOI: 10.1111/scd.12081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
117 Foulkes WD, Rosenblatt J, Chappuis PO. The contribution of inherited factors to the clinicopathological features and behavior of breast cancer. J Mammary Gland Biol Neoplasia 2001;6:453-65. [PMID: 12013534 DOI: 10.1023/a:1014791115760] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
118 Eng C. Mendelian genetics of rare--and not so rare--cancers. Ann N Y Acad Sci 2010;1214:70-82. [PMID: 20946573 DOI: 10.1111/j.1749-6632.2010.05789.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
119 Collins A, Politopoulos I. The genetics of breast cancer: risk factors for disease. Appl Clin Genet 2011;4:11-9. [PMID: 23776363 DOI: 10.2147/TACG.S13139] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
120 Van Calenbergh F, Vantomme N, Flamen P, Demaerel P, Sciot R, Legius E, Mortelmans L, Plets C. Lhermitte-Duclos disease: 11C-methionine positron emission tomography data in 4 patients. Surgical Neurology 2006;65:293-6. [DOI: 10.1016/j.surneu.2005.06.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
121 Cottin V, Thomas L, Loire R, Chalabreysse L, Gindre D, Cordier J. Mesenchymal cystic hamartoma of the lung in Cowden's disease. Respiratory Medicine 2003;97:188-91. [DOI: 10.1053/rmed.2003.1447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
122 Nosé V. Genodermatosis Affecting the Skin and Mucosa of the Head and Neck: Clinicopathologic, Genetic, and Molecular Aspect--PTEN-Hamartoma Tumor Syndrome/Cowden Syndrome. Head Neck Pathol 2016;10:131-8. [PMID: 26975628 DOI: 10.1007/s12105-016-0708-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
123 Lakeman IMM, Schmidt MK, van Asperen CJ, Devilee P. Breast Cancer Susceptibility—Towards Individualised Risk Prediction. Curr Genet Med Rep 2019;7:124-35. [DOI: 10.1007/s40142-019-00168-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Palma M, Ristori E, Ricevuto E, Giannini G, Gulino A. BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers. Crit Rev Oncol Hematol 2006;57:1-23. [PMID: 16337408 DOI: 10.1016/j.critrevonc.2005.05.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
125 Evans DG, Howell A. Breast cancer risk-assessment models. Breast Cancer Res 2007;9:213. [PMID: 17888188 DOI: 10.1186/bcr1750] [Cited by in Crossref: 88] [Cited by in F6Publishing: 65] [Article Influence: 6.8] [Reference Citation Analysis]
126 Bauer AJ, Stratakis CA. The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis. J Med Genet 2005;42:801-10. [PMID: 15958502 DOI: 10.1136/jmg.2003.017806] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
127 Hill ADK, Doyle JM, Mcdermott EW, O'higgins NJ. Hereditary breast cancer: HEREDITARY BREAST CANCER. Br J Surg 1997;84:1334-9. [DOI: 10.1111/j.1365-2168.1997.00527.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
128 Scheper MA, Nikitakis NG, Sarlani E, Sauk JJ, Meiller TF. Cowden syndrome: report of a case with immunohistochemical analysis and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:625-31. [PMID: 16632275 DOI: 10.1016/j.tripleo.2005.06.026] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
129 Cohen MM. Some neoplasms and some hamartomatous syndromes: genetic considerations. International Journal of Oral and Maxillofacial Surgery 1998;27:363-9. [DOI: 10.1016/s0901-5027(98)80066-0] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
130 Eng C, Ji H. Molecular classification of the inherited hamartoma polyposis syndromes: clearing the muddied waters. Am J Hum Genet 1998;62:1020-2. [PMID: 9545417 DOI: 10.1086/301847] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 2.3] [Reference Citation Analysis]
131 Cappell MS. The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps. Med Clin North Am. 2005;89:1-42, vii. [PMID: 15527807 DOI: 10.1016/j.mcna.2004.08.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
132 Goffin A, Hoefsloot LH, Bosgoed E, Swillen A, Fryns JP. PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 2001;105:521-4. [PMID: 11496368 DOI: 10.1002/ajmg.1477] [Cited by in Crossref: 141] [Cited by in F6Publishing: 144] [Article Influence: 7.1] [Reference Citation Analysis]
133 Hornick JL, Odze RD. Polyps of the Large Intestine. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 481-533. [DOI: 10.1016/b978-141604059-0.50022-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
134 Bonneau D, Longy M. Mutations of the human PTEN gene. Hum Mutat 2000;16:109-22. [PMID: 10923032 DOI: 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0] [Cited by in Crossref: 190] [Cited by in F6Publishing: 83] [Article Influence: 9.0] [Reference Citation Analysis]
135 Lopiccolo J, Ballas MS, Dennis PA. PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development. Crit Rev Oncol Hematol 2007;63:203-14. [PMID: 17643312 DOI: 10.1016/j.critrevonc.2007.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
136 Arver B, Du Q, Chen J, Luo L, Lindblom A. Hereditary breast cancer: a review. Seminars in Cancer Biology 2000;10:271-88. [DOI: 10.1006/scbi.2000.0325] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
137 Hemmings CT. Thyroid pathology in four patients with Cowden’s disease. Pathology 2003;35:311-4. [DOI: 10.1080/0031302031000150533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
138 John M. Carethers MD. Hamartomatous polyposis syndromes: genetic pathways. Current Opinion in Gastroenterology. 2002;18:60-67. [PMID: 17031232 DOI: 10.1097/00001574-200201000-00011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
139 Walker SM, Gautam R, Turkbey B, Malayeri A, Choyke PL. Update on Hereditary Renal Cancer and Imaging Implications. Radiol Clin North Am 2020;58:951-63. [PMID: 32792126 DOI: 10.1016/j.rcl.2020.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Bronner MP. Gastrointestinal polyposis syndromes. Am J Med Genet A 2003;122A:335-41. [PMID: 14518072 DOI: 10.1002/ajmg.a.20476] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
141 Parsons R. Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol. 2004;15:171-176. [PMID: 15209376 DOI: 10.1016/j.semcdb.2003.12.021] [Cited by in Crossref: 153] [Cited by in F6Publishing: 143] [Article Influence: 9.0] [Reference Citation Analysis]
142 Mehenni H, Friedl W, Nelen MR, Hutter P, Brundler MA. An unexpected Cowden syndrome case found among members of a large familial adenomatous polyposis kindred: . European Journal of Gastroenterology & Hepatology 2005;17:1407-12. [DOI: 10.1097/01.meg.0000184983.38398.b6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Evans DG, Lalloo F. Risk assessment and management of high risk familial breast cancer. J Med Genet 2002;39:865-71. [PMID: 12471197 DOI: 10.1136/jmg.39.12.865] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
144 Yehia L, Eng C. PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation? Hum Mol Genet 2020;29:R150-7. [PMID: 32568377 DOI: 10.1093/hmg/ddaa127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Koeller KK, Henry JM. From the archives of the AFIP: superficial gliomas: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics 2001;21:1533-56. [PMID: 11706224 DOI: 10.1148/radiographics.21.6.g01nv051533] [Cited by in Crossref: 99] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
146 Somoano B, Niendorf KB, Tsao H. Hereditary cancer syndromes of the skin. Clinics in Dermatology 2005;23:85-106. [DOI: 10.1016/j.clindermatol.2004.09.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
147 Marsh D, Zori R. Genetic insights into familial cancers-- update and recent discoveries. Cancer Lett 2002;181:125-64. [PMID: 12175530 DOI: 10.1016/s0304-3835(02)00023-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
148 Palmero EI, Galvão HC, Fernandes GC, Paula AE, Oliveira JC, Souza CP, Andrade CE, Romagnolo LG, Volc S, C Neto M, Sabato C, Grasel R, Mauad E, Reis RM, Michelli RA. Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital. Genet Mol Biol 2016;39:168-77. [PMID: 27192127 DOI: 10.1590/1678-4685-GMB-2014-0364] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
149 Mester J, Eng C. Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome. Genet Med 2012;14:819-22. [PMID: 22595938 DOI: 10.1038/gim.2012.51] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
150 Evans DG, Ingham SL. Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Appl Clin Genet 2013;6:53-61. [PMID: 23935382 DOI: 10.2147/TACG.S35605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
151 Stanich PP, Pilarski R, Rock J, Frankel WL, El-Dika S, Meyer MM. Colonic manifestations of PTEN hamartoma tumor syndrome: Case series and systematic review. World J Gastroenterol 2014; 20(7): 1833-1838 [PMID: 24587660 DOI: 10.3748/wjg.v20.i7.1833] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
152 Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res 1999;1:14-7. [PMID: 11250676 DOI: 10.1186/bcr6] [Cited by in Crossref: 202] [Cited by in F6Publishing: 171] [Article Influence: 9.2] [Reference Citation Analysis]
153 Devi M, Leonard N, Silverman S, Al-Qahtani M, Girgis R. Testicular mixed germ cell tumor in an adolescent with cowden disease. Oncology. 2007;72:194-196. [PMID: 18160807 DOI: 10.1159/000112825] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
154 Woodhouse J, Ferguson MM. Multiple hyperechoic testicular lesions are a common finding on ultrasound in Cowden disease and represent lipomatosis of the testis. Br J Radiol 2006;79:801-3. [PMID: 16980675 DOI: 10.1259/bjr/50628431] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
155 Zhou XP, Woodford-Richens K, Lehtonen R, Kurose K, Aldred M, Hampel H, Launonen V, Virta S, Pilarski R, Salovaara R, Bodmer WF, Conrad BA, Dunlop M, Hodgson SV, Iwama T, Järvinen H, Kellokumpu I, Kim JC, Leggett B, Markie D, Mecklin JP, Neale K, Phillips R, Piris J, Rozen P, Houlston RS, Aaltonen LA, Tomlinson IP, Eng C. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 2001;69:704-11. [PMID: 11536076 DOI: 10.1086/323703] [Cited by in Crossref: 166] [Cited by in F6Publishing: 150] [Article Influence: 8.3] [Reference Citation Analysis]
156 Colby S, Yehia L, Niazi F, Chen J, Ni Y, Mester JL, Eng C. Exome sequencing reveals germline gain-of-function EGFR mutation in an adult with Lhermitte-Duclos disease. Cold Spring Harb Mol Case Stud 2016;2:a001230. [PMID: 27900366 DOI: 10.1101/mcs.a001230] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
157 Fletcher B, Goldstein DB, Bradman AL, Weale ME, Bradman N, Thomas MG. High-throughput analysis of informative CYP2D6 compound haplotypes. Genomics 2003;81:166-74. [PMID: 12620394 DOI: 10.1016/s0888-7543(02)00031-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
158 Raizis AM, Ferguson MM, Nicholls DT, Goodisson DW, George PM. A Novel 5′ (40^41insA) Mutation in a Patient with Numerous Manifestations of Cowden Disease. Journal of Investigative Dermatology 2000;114:597-8. [DOI: 10.1046/j.1523-1747.2000.02002.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
159 Calzone KA. Predisposition testing for breast and ovarian cancer susceptibility. Seminars in Oncology Nursing 1997;13:82-90. [DOI: 10.1016/s0749-2081(97)80004-6] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
160 Phillips LS, Thompson CL, Merkulova A, Plummer SJ, Tucker TC, Casey G, Li L. No association between phosphatase and tensin homolog genetic polymorphisms and colon cancer. World J Gastroenterol 2009; 15(30): 3771-3775 [PMID: 19673018 DOI: 10.3748/wjg.15.3771] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
161 Scollon S, Anglin AK, Thomas M, Turner JT, Wolfe Schneider K. A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes. J Genet Couns 2017;26:387-434. [PMID: 28357779 DOI: 10.1007/s10897-017-0077-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
162 Waite KA, Eng C. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Human Molecular Genetics 2003;12:679-84. [DOI: 10.1093/hmg/ddg069] [Cited by in Crossref: 68] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
163 Smerdel MP, Skytte AB, Jelsig AM, Ebbehøj E, Stochholm K. Revised Danish guidelines for the cancer surveillance of patients with Cowden Syndrome. Eur J Med Genet 2020;63:103873. [PMID: 32058060 DOI: 10.1016/j.ejmg.2020.103873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
164 Turnbull C, Mirugaesu N, Eeles R. Radiotherapy and genetic predisposition to breast cancer. Clin Oncol (R Coll Radiol) 2006;18:257-67. [PMID: 16605057 DOI: 10.1016/j.clon.2005.11.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
165 Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L, Malone KE, Ursin G, Strom BL. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346:2025-2032. [PMID: 12087137 DOI: 10.1016/j.molonc.2010.04.011] [Cited by in Crossref: 212] [Cited by in F6Publishing: 196] [Article Influence: 11.2] [Reference Citation Analysis]
166 Kimura F, Ueda A, Sato E, Akimoto J, Kaise H, Yamada K, Hosonaga M, Kawai Y, Teraoka S, Okazaki M, Ishikawa T. Hereditary breast cancer associated with Cowden syndrome-related PTEN mutation with Lhermitte-Duclos disease. Surg Case Rep 2017;3:83. [PMID: 28741261 DOI: 10.1186/s40792-017-0355-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
167 Cohen-Haguenauer O. [Hereditary predisposition to breast cancer (1): genetics]. Med Sci (Paris) 2019;35:138-51. [PMID: 30774081 DOI: 10.1051/medsci/2019003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
168 Garcia JM, Silva J, Pena C, Garcia V, Rodriguez R, Cruz MA, Cantos B, Provencio M, Espana P, Bonilla F. Promoter methylation of the PTEN gene is a common molecular change in breast cancer. Genes Chromosomes Cancer. 2004;41:117-124. [PMID: 15287024 DOI: 10.1002/gcc.20062] [Cited by in Crossref: 152] [Cited by in F6Publishing: 148] [Article Influence: 8.9] [Reference Citation Analysis]
169 Ha M, Chung JW, Hahm KB, Kim YJ, Lee W, An J, Kim DK, Kim MG. A case of Cowden syndrome diagnosed from multiple gastric polyposis. World J Gastroenterol 2012; 18(8): 861-864 [PMID: 22371648 DOI: 10.3748/wjg.v18.i8.861] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
170 Courchesne E, Pierce K. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int j dev neurosci 2005;23:153-70. [DOI: 10.1016/j.ijdevneu.2005.01.003] [Cited by in Crossref: 253] [Cited by in F6Publishing: 217] [Article Influence: 15.8] [Reference Citation Analysis]
171 Milas M, Mester J, Metzger R, Shin J, Mitchell J, Berber E, Siperstein AE, Eng C. Should patients with Cowden syndrome undergo prophylactic thyroidectomy? Surgery 2012;152:1201-10. [PMID: 23158187 DOI: 10.1016/j.surg.2012.08.055] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
172 Douglas-akinwande AC, Payner TD, Hattab EM. Medulloblastoma mimicking Lhermitte-Duclos disease on MRI and CT. Clinical Neurology and Neurosurgery 2009;111:536-9. [DOI: 10.1016/j.clineuro.2009.01.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
173 Salo-Mullen EE, Shia J, Brownell I, Allen P, Girotra M, Robson ME, Offit K, Guillem JG, Markowitz AJ, Stadler ZK. Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome. Fam Cancer 2014;13:459-67. [PMID: 24609522 DOI: 10.1007/s10689-014-9709-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
174 Czarniecki M, Gautam R, Choyke PL, Turkbey B. Imaging findings of hereditary renal tumors, a review of what the radiologist should know. European Journal of Radiology 2018;101:8-16. [DOI: 10.1016/j.ejrad.2018.01.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
175 Marcus JN, Page DL, Watson P, Narod SA, Lenoir GM, Lynch HT. BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer 1997;80:543-56. [DOI: 10.1002/(sici)1097-0142(19970801)80:3+<543::aid-cncr4>3.0.co;2-a] [Cited by in Crossref: 34] [Article Influence: 1.4] [Reference Citation Analysis]
176 Koksal Y, Sahin M, Koksal H, Orhan D, Unal E, Alagoz E. Thyroid Medullary Carcinoma in a Teenager With Cowden Syndrome: . The Laryngoscope 2007;117:1180-2. [DOI: 10.1097/mlg.0b013e318058a0b7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
177 Shinagare AB, Patil NK, Sorte SZ. Case 144: Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease). Radiology 2009;251:298-303. [PMID: 19332858 DOI: 10.1148/radiol.2511071390] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
178 Lindor NM, Greene MH; Mayo Familial Cancer Program. The Concise Handbook of Family Cancer Syndromes. JNCI: Journal of the National Cancer Institute 1998;90:1039-71. [DOI: 10.1093/jnci/90.14.1039] [Cited by in Crossref: 219] [Cited by in F6Publishing: 171] [Article Influence: 9.5] [Reference Citation Analysis]
179 Farooq A, Walker LJ, Bowling J, Audisio RA. Cowden syndrome. Cancer Treat Rev. 2010;36:577-583. [PMID: 20580873 DOI: 10.1016/j.ctrv.2010.04.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 57] [Article Influence: 7.4] [Reference Citation Analysis]
180 Schmeler KM, Daniels MS, Brandt AC, Lu KH. Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome. Obstet Gynecol 2009;114:477-9. [PMID: 19622968 DOI: 10.1097/AOG.0b013e31819dade8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
181 Hall JE, Abdollahian DJ, Sinard RJ, Eisele DW. Thyroid disease associated with cowden syndrome: A meta-analysis. Head Neck 2013;35:1189-94. [DOI: 10.1002/hed.22971] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
182 Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009;36:237-249. [PMID: 19460581 DOI: 10.1053/j.seminoncol.2009.03.001] [Cited by in Crossref: 369] [Cited by in F6Publishing: 321] [Article Influence: 30.8] [Reference Citation Analysis]
183 Campos FG, Habr-Gama A, Kiss DR, Atuí FC, Rawet V, Goldstein PJ, Gama-Rodrigues J. Cowden syndrome: report of two cases and review of clinical presentation and management of a rare colorectal polyposis. Curr Surg 2006;63:15-9. [PMID: 16373153 DOI: 10.1016/j.cursur.2005.04.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
184 Rustad CF, Bjørnslett M, Heimdal KR, Mæhle L, Apold J, Møller P. Germline PTEN mutations are rare and highly penetrant. Hered Cancer Clin Pract 2006;4:177-85. [PMID: 20223021 DOI: 10.1186/1897-4287-4-4-177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
185 McGarrity TJ, Wagner Baker MJ, Ruggiero FM, Thiboutot DM, Hampel H, Zhou XP, Eng C. GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations. Am J Gastroenterol. 2003;98:1429-1434. [PMID: 12818292 DOI: 10.1111/j.1572-0241.2003.07496.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
186 Kim DK, Myung SJ, Yang SK, Hong SS, Kim KJ, Byeon JS, Lee GH, Kim JH, Min YI, Lee SM. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome. Dis Colon Rectum. 2005;48:1714-1722. [PMID: 16007494 DOI: 10.1007/s10350-005-0130-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
187 Löffler MW, Steinhilber J, Hilke FJ, Haen SP, Bösmüller H, Montes-Mojarro IA, Bonzheim I, Stäbler A, Faust U, Grasshoff U, Königsrainer I, Rammensee HG, Kanz L, Königsrainer A, Beckert S, Riess O, Schroeder C. First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications. BMC Med Genet 2018;19:144. [PMID: 30111295 DOI: 10.1186/s12881-018-0651-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
188 Heald B, Mester J, Rybicki L, Orloff MS, Burke CA, Eng C. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology. 2010;139:1927-1933. [PMID: 20600018 DOI: 10.1053/j.gastro.2010.06.061] [Cited by in Crossref: 175] [Cited by in F6Publishing: 133] [Article Influence: 15.9] [Reference Citation Analysis]
189 Ghoussaini M, Pharoah PDP, Easton DF. Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning? Am J Pathol. 2013;183:1038-1051. [PMID: 23973388 DOI: 10.1016/j.ajpath.2013.07.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 7.4] [Reference Citation Analysis]
190 Sherman SK, Maxwell JE, Qian Q, Bellizzi AM, Braun TA, Iannettoni MD, Darbro BW, Howe JR. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations. Cancer Genet 2015;208:41-6. [PMID: 25554686 DOI: 10.1016/j.cancergen.2014.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
191 Oldenburg R, Meijers-heijboer H, Cornelisse C, Devilee P. Genetic susceptibility for breast cancer: How many more genes to be found? Critical Reviews in Oncology/Hematology 2007;63:125-49. [DOI: 10.1016/j.critrevonc.2006.12.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
192 Kim RH, Wang X, Evans AJ, Campbell SC, Nguyen JK, Farncombe KM, Eng C. Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome. NPJ Genom Med 2020;5:40. [PMID: 33083010 DOI: 10.1038/s41525-020-00148-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Banno K, Kisu I, Yanokura M, Masuda K, Ueki A, Kobayashi Y, Susumu N, Aoki D. Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice. Epigenomics. 2012;4:147-162. [PMID: 22449187 DOI: 10.2217/epi.12.13] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
194 Jass JR. Familial colorectal cancer: pathology and molecular characteristics. Lancet Oncol 2000;1:220-6. [PMID: 11905639 DOI: 10.1016/s1470-2045(00)00152-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
195 Hill ADK, Doyle JM, Mcdermott EW, O'higgins NJ. Hereditary breast cancer. Br J Surg 1997;84:1334-9. [DOI: 10.1002/bjs.1800841004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
196 Eng C. Role of PTEN, a Lipid Phosphatase Upstream Effector of Protein Kinase B, in Epithelial Thyroid Carcinogenesis. Annals of the New York Academy of Sciences 2002;968:213-21. [DOI: 10.1111/j.1749-6632.2002.tb04337.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
197 Howe JR, Ringold JC, Summers RW, Mitros FA, Nishimura DY, Stone EM. A gene for familial juvenile polyposis maps to chromosome 18q21.1. Am J Hum Genet 1998;62:1129-36. [PMID: 9545410 DOI: 10.1086/301840] [Cited by in Crossref: 84] [Cited by in F6Publishing: 62] [Article Influence: 3.7] [Reference Citation Analysis]
198 Tsubosa Y, Fukutomi T, Tsuda H, Kanai Y, Akashi-tanaka S, Nanasawa T, Linuma G, Ushio K. Breast Cancer in Cowden's Disease: a Case Report with Review of the Literature. Japanese Journal of Clinical Oncology 1998;28:42-6. [DOI: 10.1093/jjco/28.1.42] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
199 Nagy R, Ringel MD. Genetic predisposition for nonmedullary thyroid cancer. Horm Cancer 2015;6:13-20. [PMID: 25338077 DOI: 10.1007/s12672-014-0205-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
200 Ngeow J, Sesock K, Eng C. Breast cancer risk and clinical implications for germline PTEN mutation carriers. Breast Cancer Res Treat 2017;165:1-8. [DOI: 10.1007/s10549-015-3665-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
201 Adeniran AJ, Shuch B, Humphrey PA. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol 2015;39:e1-e18. [PMID: 26559379 DOI: 10.1097/PAS.0000000000000562] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 6.8] [Reference Citation Analysis]
202 Somoano B, Tsao H. Genodermatoses with Cutaneous Tumors and Internal Malignancies. Dermatologic Clinics 2008;26:69-87. [DOI: 10.1016/j.det.2007.08.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
203 Stratton MR. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. The Lancet 1997;349:1505-10. [DOI: 10.1016/s0140-6736(96)10109-4] [Cited by in Crossref: 417] [Cited by in F6Publishing: 2] [Article Influence: 17.4] [Reference Citation Analysis]
204 Ngeow J, Eng C. PTEN in Hereditary and Sporadic Cancer. Cold Spring Harb Perspect Med 2020;10:a036087. [PMID: 31570378 DOI: 10.1101/cshperspect.a036087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
205 Peirã³ G, Adrover E, Guijarro J, Ballester I, Josã© Jimenez M, Planelles M, Catasãºs L. Synchronous Bilateral Breast Carcinoma in a Patient with Cowden Syndrome: A Case Report with Morphologic, Immunohistochemical and Genetic Analysis. The Breast Journal 2010;16:77-81. [DOI: 10.1111/j.1524-4741.2009.00846.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
206 Suphapeetiporn K, Kongkam P, Tantivatana J, Sinthuwiwat T, Tongkobpetch S, Shotelersuk V. PTEN c.511C>T nonsense mutation in a BRRS family disrupts a potential exonic splicing enhancer and causes exon skipping. Jpn J Clin Oncol 2006;36:814-21. [PMID: 17043057 DOI: 10.1093/jjco/hyl107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
207 Lynch HT, Fusaro RM, Lynch JF. Cancer genetics in the new era of molecular biology. Ann N Y Acad Sci. 1997;833:1-28. [PMID: 9616736 DOI: 10.1111/j.1749-6632.1997.tb48588.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
208 Kim B, Tabori U, Hawkins C. An update on the CNS manifestations of brain tumor polyposis syndromes. Acta Neuropathol 2020;139:703-15. [PMID: 31970492 DOI: 10.1007/s00401-020-02124-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
209 Mester J, Eng C. When overgrowth bumps into cancer: the PTEN-opathies. Am J Med Genet C Semin Med Genet 2013;163C:114-21. [PMID: 23613428 DOI: 10.1002/ajmg.c.31364] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 10.9] [Reference Citation Analysis]
210 Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK, Eng C. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int J Cancer. 2002;99:63-67. [PMID: 11948493 DOI: 10.1002/ijc.10294] [Cited by in Crossref: 121] [Cited by in F6Publishing: 120] [Article Influence: 6.4] [Reference Citation Analysis]
211 Nosé V. Thyroid cancer of follicular cell origin in inherited tumor syndromes. Adv Anat Pathol 2010;17:428-36. [PMID: 20966648 DOI: 10.1097/PAP.0b013e3181f8b028] [Cited by in Crossref: 40] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
212 O'Hare AM, Cooper PH, Parlette HL 3rd. Trichilemmomal carcinoma in a patient with Cowden's disease (multiple hamartoma syndrome). J Am Acad Dermatol 1997;36:1021-3. [PMID: 9204076 DOI: 10.1016/s0190-9622(97)80295-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
213 Villeneuve H, Tremblay S, Galiatsatos P, Hamel N, Guertin L, Morency R, Tischkowitz M. Acinic cell carcinoma of the retromolar trigone region: expanding the tumor phenotype in Cowden syndrome? Fam Cancer 2011;10:691-4. [PMID: 21822720 DOI: 10.1007/s10689-011-9472-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
214 Horvath A, Pakala SB, Mudvari P, Reddy SD, Ohshiro K, Casimiro S, Pires R, Fuqua SA, Toi M, Costa L, Nair SS, Sukumar S, Kumar R. Novel insights into breast cancer genetic variance through RNA sequencing. Sci Rep 2013;3:2256. [PMID: 23884293 DOI: 10.1038/srep02256] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
215 Jacoby RF, Schlack S, Sekhon G, Laxova R. Del(10)(q22.3q24.1) associated with juvenile polyposis. Am J Med Genet 1997;70:361-4. [DOI: 10.1002/(sici)1096-8628(19970627)70:4<361::aid-ajmg6>3.0.co;2-w] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
216 Jatoi I, Benson JR. Management of women with a hereditary predisposition for breast cancer. Future Oncology 2016;12:2277-88. [DOI: 10.2217/fon-2016-0186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
217 Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, Edelman E, Platzer P, Orloff MS, Waite KA, Eng C. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet 2008;83:261-8. [PMID: 18678321 DOI: 10.1016/j.ajhg.2008.07.011] [Cited by in Crossref: 156] [Cited by in F6Publishing: 126] [Article Influence: 12.0] [Reference Citation Analysis]
218 Tan T, Ho L. Lhermitte-Duclos disease associated with Cowden syndrome. Journal of Clinical Neuroscience 2007;14:801-5. [DOI: 10.1016/j.jocn.2006.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
219 Smith IN, Thacker S, Seyfi M, Cheng F, Eng C. Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer. Am J Hum Genet 2019;104:861-78. [PMID: 31006514 DOI: 10.1016/j.ajhg.2019.03.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
220 Soysal Y, Tate G, Polat C, Polat N, Aktepe F, Sıvacı Y, Imirzalıoglu N. Analysis of PTEN Gene Mutations in a Turkish Patient with Cowden Syndrome. Genetic Testing and Molecular Biomarkers 2009;13:547-51. [DOI: 10.1089/gtmb.2009.0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
221 Menashe I, Maeder D, Garcia-Closas M, Figueroa JD, Bhattacharjee S, Rotunno M, Kraft P, Hunter DJ, Chanock SJ, Rosenberg PS, Chatterjee N. Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res 2010;70:4453-9. [PMID: 20460509 DOI: 10.1158/0008-5472.CAN-09-4502] [Cited by in Crossref: 93] [Cited by in F6Publishing: 62] [Article Influence: 8.5] [Reference Citation Analysis]
222 Greene AK, Goss JA. Vascular Anomalies: From a Clinicohistologic to a Genetic Framework. Plast Reconstr Surg 2018;141:709e-17e. [PMID: 29697621 DOI: 10.1097/PRS.0000000000004294] [Cited by in Crossref: 54] [Cited by in F6Publishing: 24] [Article Influence: 18.0] [Reference Citation Analysis]
223 Robinson S, Cohen AR. Cowden disease and Lhermitte-Duclos disease: an update. Case report and review of the literature. Neurosurg Focus 2006;20:E6. [PMID: 16459996 DOI: 10.3171/foc.2006.20.1.7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
224 Tomita-mitchell A, Muniappan BP, Herrero-jimenez P, Zarbl H, Thilly WG. Single nucleotide polymorphism spectra in newborns and centenarians: identification of genes coding for rise of mortal disease1Published in conjunction with A Wisconsin Gathering Honouring Waclaw Szybalski on the occasion of his 75th year and 20 years of Editorship-in-Chief of Gene, 10–11 August 1997, University of Wisconsin, Madison, WI, USA.1. Gene 1998;223:381-91. [DOI: 10.1016/s0378-1119(98)00408-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
225 Hammerschmidt M, Lourenço SV, Nico MMS. A clinicopathological study of the oral lesions of Cowden disease. J Oral Pathol Med 2017;46:637-43. [PMID: 27889943 DOI: 10.1111/jop.12519] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Arch EM, Goodman BK, Wesep RV, Liaw D, Clarke K, Parsons R, Mckusick VA, Geraghty MT. Deletion ofPTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet 1997;71:489-93. [DOI: 10.1002/(sici)1096-8628(19970905)71:4<489::aid-ajmg24>3.0.co;2-b] [Cited by in Crossref: 85] [Article Influence: 3.5] [Reference Citation Analysis]
227 Nakagawa T, Maeda M, Kato M, Terada N, Shimizu S, Morooka Y, Nakano H, Takeda K. A case of Lhermitte-Duclos disease presenting high FDG uptake on FDG-PET/CT. J Neurooncol 2007;84:185-8. [DOI: 10.1007/s11060-007-9355-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
228 Calva D, Howe JR. Hamartomatous polyposis syndromes. Surg Clin North Am. 2008;88:779-817, vii. [PMID: 18672141 DOI: 10.1016/j.suc.2008.05.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
229 Miguelote S, Silva R, Fougo JL, Barbosa LE, Araújo Teixeira JP. Cowden syndrome is a risk factor for multiple neoplasm: a case report. World J Surg Oncol 2020;18:211. [PMID: 32807196 DOI: 10.1186/s12957-020-01971-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Wanner M, Celebi JT, Peacocke M. Identification of a PTEN mutation in a family with Cowden syndrome and Bannayan-Zonana syndrome. J Am Acad Dermatol 2001;44:183-7. [PMID: 11174374 DOI: 10.1067/mjd.2001.110390] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
231 Wang Q, Von T, Bronson R, Ruan M, Mu W, Huang A, Maira SM, Zhao JJ. Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome. Genes Dev 2013;27:1568-80. [PMID: 23873941 DOI: 10.1101/gad.216069.113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
232 Leslie NR, Longy M. Inherited PTEN mutations and the prediction of phenotype. Seminars in Cell & Developmental Biology 2016;52:30-8. [DOI: 10.1016/j.semcdb.2016.01.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
233 Tilot AK, Frazier TW 2nd, Eng C. Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder. Neurotherapeutics 2015;12:609-19. [PMID: 25916396 DOI: 10.1007/s13311-015-0356-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
234 Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns. 2009;18:13-27. [PMID: 18972196 DOI: 10.1007/s10897-008-9187-7] [Cited by in Crossref: 198] [Cited by in F6Publishing: 123] [Article Influence: 15.2] [Reference Citation Analysis]
235 Zori RT, Marsh DJ, Graham GE, Marliss EB, Eng C. GermlinePTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba Syndrome. Am J Med Genet 1998;80:399-402. [DOI: 10.1002/(sici)1096-8628(19981204)80:4<399::aid-ajmg18>3.0.co;2-o] [Cited by in Crossref: 72] [Article Influence: 3.1] [Reference Citation Analysis]
236 Macken WL, Tischkowitz M, Lachlan KL. PTEN Hamartoma tumor syndrome in childhood: A review of the clinical literature. Am J Med Genet C Semin Med Genet 2019;181:591-610. [PMID: 31609537 DOI: 10.1002/ajmg.c.31743] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
237 Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G, Vogelstein B. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet. 2001;28:184-187. [PMID: 11381269 DOI: 10.1038/88919] [Cited by in Crossref: 429] [Cited by in F6Publishing: 381] [Article Influence: 21.5] [Reference Citation Analysis]
238 Isik E, Simsir OS, Solmaz AE, Onay H, Atik T, Aykut A, Durmaz A, Cogulu O, Ozkinay F. Clinical and molecular aspects of PTEN mutations in 10 pediatric patients. Annals of Human Genetics 2020;84:324-30. [DOI: 10.1111/ahg.12380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
239 Halachmi N, Halachmi S, Evron E, Cairns P, Okami K, Saji M, Westra WH, Zeiger MA, Jen J, Sidransky D. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer 1998;23:239-43. [PMID: 9790504 DOI: 10.1002/(sici)1098-2264(199811)23:3<239::aid-gcc5>3.0.co;2-2] [Cited by in Crossref: 84] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
240 Tahmasebi S, Khoutorsky A, Mathews MB, Sonenberg N. Translation deregulation in human disease. Nat Rev Mol Cell Biol 2018;19:791-807. [PMID: 30038383 DOI: 10.1038/s41580-018-0034-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 69] [Article Influence: 42.0] [Reference Citation Analysis]
241 Podralska M, Nowakowska D, Steffen J, Cichy W, Slomski R, Plawski A. First Polish Cowden syndrome patient with confirmed PTEN gene mutation. Arch Med Sci 2010;6:135-7. [PMID: 22371735 DOI: 10.5114/aoms.2010.13522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
242 Perren A, Komminoth P, Saremaslani P, Matter C, Feurer S, Lees JA, Heitz PU, Eng C. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 2000;157:1097-103. [PMID: 11021813 DOI: 10.1016/S0002-9440(10)64624-X] [Cited by in Crossref: 194] [Cited by in F6Publishing: 83] [Article Influence: 9.2] [Reference Citation Analysis]
243 Lymberis SC, Parhar PK, Katsoulakis E, Formenti SC. Pharmacogenomics and breast cancer. Pharmacogenomics 2004;5:31-55. [PMID: 14683419 DOI: 10.1517/phgs.5.1.31.25686] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
244 Barletta JA, Bellizzi AM, Hornick JL. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome. Am J Surg Pathol 2011;35:1505-11. [PMID: 21921783 DOI: 10.1097/PAS.0b013e31822fbc7d] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
245 Wong A, Ngeow J. Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? Biomed Res Int 2015;2015:219012. [PMID: 26161390 DOI: 10.1155/2015/219012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
246 Gruhl SL, Sharma P, Han TS. A family with PTEN mutations with malignancy and an unusually high number of offspring with autism spectrum disorder: a case report. J Med Case Rep 2018;12:353. [PMID: 30482242 DOI: 10.1186/s13256-018-1863-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
247 Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, Fahey TJ 3rd, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg 2020;271:e21-93. [PMID: 32079830 DOI: 10.1097/SLA.0000000000003580] [Cited by in Crossref: 71] [Cited by in F6Publishing: 29] [Article Influence: 71.0] [Reference Citation Analysis]
248 Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer. 2002;86:76-83. [PMID: 11857015 DOI: 10.1038/sj.bjc.6600008] [Cited by in Crossref: 301] [Cited by in F6Publishing: 247] [Article Influence: 15.8] [Reference Citation Analysis]
249 Puxeddu E, Zhao G, Stringer JR, Medvedovic M, Moretti S, Fagin JA. Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens. Mutat Res 2005;570:17-32. [PMID: 15680400 DOI: 10.1016/j.mrfmmm.2004.09.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
250 Raizis AM, Ferguson MM, Robinson BA, Atkinson CH, George PM. Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome. Mol Pathol 1998;51:339-41. [PMID: 10193515 DOI: 10.1136/mp.51.6.339] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
251 Laskin WB, Fetsch JF, Michal M, Miettinen M. Sclerotic (fibroma-like) lipoma: a distinctive lipoma variant with a predilection for the distal extremities. Am J Dermatopathol. 2006;28:308-316. [PMID: 16871033 DOI: 10.1097/00000372-200608000-00003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
252 Agrawal S, Pilarski R, Eng C. Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN. Human Molecular Genetics 2005;14:2459-68. [DOI: 10.1093/hmg/ddi246] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
253 Leung C, Pan S, Shuch B. Management of renal cell carcinoma in young patients and patients with hereditary syndromes. Current Opinion in Urology 2016;26:396-404. [DOI: 10.1097/mou.0000000000000322] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
254 Eng C. Constipation, polyps, or cancer? letPTEN predict your future. Am J Med Genet 2003;122A:315-22. [DOI: 10.1002/ajmg.a.20477] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
255 Peiling Yang S, Ngeow J. Familial non-medullary thyroid cancer: unraveling the genetic maze. Endocr Relat Cancer 2016;23:R577-95. [PMID: 27807061 DOI: 10.1530/ERC-16-0067] [Cited by in Crossref: 61] [Cited by in F6Publishing: 25] [Article Influence: 12.2] [Reference Citation Analysis]
256 Edwards JM, Alsop S, Modesitt SC. Coexisting atypical polypoid adenomyoma and endometrioid endometrial carcinoma in a young woman with Cowden Syndrome: Case report and implications for screening and prevention. Gynecol Oncol Case Rep 2012;2:29-31. [PMID: 24371612 DOI: 10.1016/j.gynor.2011.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
257 Guerra L, Castori M, Didona B, Castiglia D, Zambruno G. Hereditary palmoplantar keratodermas. Part II: syndromic palmoplantar keratodermas - Diagnostic algorithm and principles of therapy. J Eur Acad Dermatol Venereol 2018;32:899-925. [DOI: 10.1111/jdv.14834] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
258 Beguinot F. PTEN targeting: the search for novel insulin sensitisers provides new insight into obesity research. Diabetologia 2007;50:247-9. [DOI: 10.1007/s00125-006-0547-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
259 Stratakis CA. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J Endocrinol Invest 2001;24:370-83. [PMID: 11407658 DOI: 10.1007/BF03343875] [Cited by in Crossref: 35] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
260 Barkovich AJ, Millen KJ, Dobyns WB. A developmental and genetic classification for midbrain-hindbrain malformations. Brain 2009;132:3199-230. [PMID: 19933510 DOI: 10.1093/brain/awp247] [Cited by in Crossref: 185] [Cited by in F6Publishing: 128] [Article Influence: 16.8] [Reference Citation Analysis]
261 Eng C, Peacocke M. PTEN and inherited hamartoma-cancer syndromes. Nat Genet 1998;19:223-223. [DOI: 10.1038/897] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
262 Bellosillo B, Tusquets I. Pitfalls and Caveats in BRCA Sequencing. Ultrastructural Pathology 2009;30:229-35. [DOI: 10.1080/01913120500521281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
263 Rainville IR, Rana HQ. Next-generation sequencing for inherited breast cancer risk: counseling through the complexity. Curr Oncol Rep. 2014;16:371. [PMID: 24488544 DOI: 10.1007/s11912-013-0371-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
264 Frayling IM, Bodmer WF, Tomlinson IP. Allele loss in colorectal cancer at the Cowden disease/Juvenile Polyposis locus on 10q. Cancer Genetics and Cytogenetics 1997;97:64-9. [DOI: 10.1016/s0165-4608(97)00011-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
265 Kohno T, Takahashi M, Fukutomi T, Ushio K, Yokota J. Germline mutations of the PTEN/MMAC1 gene in Japanese patients with Cowden disease. Jpn J Cancer Res 1998;89:471-4. [PMID: 9685848 DOI: 10.1111/j.1349-7006.1998.tb03285.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
266 Karppinen SM, Erkko H, Reini K, Pospiech H, Heikkinen K, Rapakko K, Syväoja JE, Winqvist R. Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer. Eur J Cancer 2006;42:2647-52. [PMID: 16930991 DOI: 10.1016/j.ejca.2006.05.030] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
267 Aloraifi F, Alshehhi M, Mcdevitt T, Cody N, Meany M, O'doherty A, Quinn C, Green A, Bracken A, Geraghty J. Phenotypic analysis of familial breast cancer: Comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer. European Journal of Surgical Oncology (EJSO) 2015;41:641-6. [DOI: 10.1016/j.ejso.2015.01.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
268 Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15:356-362. [PMID: 9090379 DOI: 10.1038/ng0497-356] [Cited by in Crossref: 1854] [Cited by in F6Publishing: 1780] [Article Influence: 77.3] [Reference Citation Analysis]
269 Weitzel JN. The Genetics of Breast Cancer: What the Surgical Oncologist Needs to Know. Surg Oncol Clin N Am 2015;24:705-32. [PMID: 26363538 DOI: 10.1016/j.soc.2015.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
270 Hirsch AE, Atencio DP, Rosenstein BS. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer. Breast Cancer Res Treat 2008;107:139-44. [PMID: 17333338 DOI: 10.1007/s10549-007-9531-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
271 Yehia L, Eng C. Largescale population genomics versus deep phenotyping: Brute force or elegant pragmatism towards precision medicine. NPJ Genom Med 2019;4:6. [PMID: 30937181 DOI: 10.1038/s41525-019-0080-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
272 Chen HJ, Romigh T, Sesock K, Eng C. Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome. Hum Mutat 2017;38:1372-7. [PMID: 28677221 DOI: 10.1002/humu.23288] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
273 Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur J Cancer 2003;39:2632-42. [PMID: 14642925 DOI: 10.1016/s0959-8049(03)00669-5] [Cited by in Crossref: 100] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
274 Adachi T, Takigawa H, Nomura T, Watanabe Y, Kowa H. Cowden Syndrome with a Novel PTEN Mutation Presenting with Partial Epilepsy Related to Focal Cortical Dysplasia. Intern Med 2018;57:97-9. [PMID: 29033429 DOI: 10.2169/internalmedicine.9052-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
275 Tsao H. Update on familial cancer syndromes and the skin. Journal of the American Academy of Dermatology 2000;42:939-69. [DOI: 10.1067/mjd.2000.104681] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
276 Sansal I, Sellers WR. The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway. JCO 2004;22:2954-63. [DOI: 10.1200/jco.2004.02.141] [Cited by in Crossref: 638] [Cited by in F6Publishing: 284] [Article Influence: 37.5] [Reference Citation Analysis]
277 Huusko P, Juo SH, Gillanders E, Sarantaus L, Kainu T, Vahteristo P, Allinen M, Jones M, Rapakko K, Eerola H, Markey C, Vehmanen P, Gildea D, Freas-Lutz D, Blomqvist C, Leisti J, Blanco G, Puistola U, Trent J, Bailey-Wilson J, Winqvist R, Nevanlinna H, Kallioniemi OP. Genome-wide scanning for linkage in Finnish breast cancer families. Eur J Hum Genet 2004;12:98-104. [PMID: 14560309 DOI: 10.1038/sj.ejhg.5201091] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
278 Stanich PP, Owens VL, Sweetser S, Khambatta S, Smyrk TC, Richardson RL, Goetz MP, Patnaik MM. Colonic polyposis and neoplasia in Cowden syndrome. Mayo Clin Proc. 2011;86:489-492. [PMID: 21628613 DOI: 10.4065/mcp.2010.0816] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
279 Sawada T, Hamano N, Satoh H, Okada T, Takeda Y, Mabuchi H. Mutation analysis of the PTEN / MMAC1 gene in Japanese patients with Cowden disease. Jpn J Cancer Res 2000;91:700-5. [PMID: 10920277 DOI: 10.1111/j.1349-7006.2000.tb01002.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
280 Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab. 2011;96:E2063-E2071. [PMID: 21956414 DOI: 10.1210/jc.2011-1616] [Cited by in Crossref: 116] [Cited by in F6Publishing: 92] [Article Influence: 11.6] [Reference Citation Analysis]
281 Papageorgiou T, Stratakis CA. Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease). Int J Gynecol Cancer 2002;12:337-47. [PMID: 12144681 DOI: 10.1046/j.1525-1438.2002.01147.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
282 Callahan R. The Role of Tumor Suppressor Genes in Breast Cancer Progression. In: Manni A, editor. Endocrinology of Breast Cancer. Totowa: Humana Press; 1999. pp. 119-32. [DOI: 10.1007/978-1-59259-699-7_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
283 DiLiberti JH. Inherited macrocephaly-hamartoma syndromes. Am J Med Genet 1998;79:284-90. [PMID: 9781909 DOI: 10.1002/(sici)1096-8628(19981002)79:4<284::aid-ajmg10>3.0.co;2-n] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
284 Lam KK, Thean LF, Cheah PY. Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention. Int J Biochem Cell Biol 2021;137:106032. [PMID: 34182137 DOI: 10.1016/j.biocel.2021.106032] [Reference Citation Analysis]
285 Shi L, Ko S, Ko ML, Kim AJ, Ko GY. Peptide Lv augments L-type voltage-gated calcium channels through vascular endothelial growth factor receptor 2 (VEGFR2) signaling. Biochim Biophys Acta 2015;1853:1154-64. [PMID: 25698653 DOI: 10.1016/j.bbamcr.2015.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
286 Yehia L, Ngeow J, Eng C. PTEN-opathies: from biological insights to evidence-based precision medicine. J Clin Invest 2019;129:452-64. [PMID: 30614812 DOI: 10.1172/JCI121277] [Cited by in Crossref: 64] [Cited by in F6Publishing: 37] [Article Influence: 32.0] [Reference Citation Analysis]
287 Jass JR. Broadsheet number 52: molecular genetics of colorectal cancer. Pathology 1999;31:354-64. [DOI: 10.1080/003130299104729] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
288 McInerney NM, Narod S, Metcalfe K, Semple J, Brown MH. Breast Cancer Genetics for Plastic Surgeons. Plast Reconstr Surg 2017;140:455-60. [PMID: 28841602 DOI: 10.1097/PRS.0000000000003577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
289 Falkenberry SS, Legare RD. Risk factors for breast cancer. Obstet Gynecol Clin North Am 2002;29:159-72. [PMID: 11892864 DOI: 10.1016/s0889-8545(03)00059-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
290 Ciaccio C, Saletti V, D'Arrigo S, Esposito S, Alfei E, Moroni I, Tonduti D, Chiapparini L, Pantaleoni C, Milani D. Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur J Med Genet 2019;62:103596. [PMID: 30528446 DOI: 10.1016/j.ejmg.2018.12.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
291 Huntoon K, Toland AMS, Dahiya S. Meningioma: A Review of Clinicopathological and Molecular Aspects. Front Oncol 2020;10:579599. [PMID: 33194703 DOI: 10.3389/fonc.2020.579599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
292 Lim A, Ngeow J. The Skin in Cowden Syndrome. Front Med (Lausanne) 2021;8:658842. [PMID: 34179044 DOI: 10.3389/fmed.2021.658842] [Reference Citation Analysis]
293 Tsuchiya KD, Wiesner G, Cassidy SB, Limwongse C, Boyle JT, Schwartz S. Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome. Genes Chromosomes Cancer 1998;21:113-8. [PMID: 9491322 DOI: 10.1002/(sici)1098-2264(199802)21:2<113::aid-gcc6>3.0.co;2-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
294 Dörk T, Hillemanns P, Tempfer C, Breu J, Fleisch MC. Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management. Cancers (Basel) 2020;12:E2407. [PMID: 32854222 DOI: 10.3390/cancers12092407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
295 Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012;18:400-407. [PMID: 22252256 DOI: 10.1158/1078-0432.ccr-11-2283] [Cited by in Crossref: 500] [Cited by in F6Publishing: 214] [Article Influence: 55.6] [Reference Citation Analysis]
296 Cho MY, Kim HS, Eng C, Kim DS, Kang SJ, Eom M, Yi SY, Bronner MP. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity. Am J Surg Pathol 2008;32:1258-64. [PMID: 18594467 DOI: 10.1097/PAS.0b013e31816be8b7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
297 Amagasa M, Yuda F, Tsunoda T, Sato S. Lhermitte-duclos disease associated with Cowden disease. Brain Tumor Pathol 1997;14:63-9. [DOI: 10.1007/bf02478871] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
298 Snyder C, Hampel H. Hereditary Colorectal Cancer Syndromes.Semin Oncol Nurs. 2019;35:58-78. [PMID: 30665732 DOI: 10.1016/j.soncn.2018.12.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
299 Gammon A, Jasperson K, Champine M. Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. Appl Clin Genet 2016;9:83-92. [PMID: 27471403 DOI: 10.2147/TACG.S41947] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
300 Kurland JE, Beck SE, Solomon CJ, Brann OS, Carethers JM, Huang SC. Cyclooxygenase-2 expression in polyps from a patient with juvenile polyposis syndrome with mutant BMPR1A. J Pediatr Gastroenterol Nutr. 2007;44:318-325. [PMID: 17325551 DOI: 10.1097/MPG.0b013e31802e98e5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
301 Thull DL, Vogel VG. Recognition and management of hereditary breast cancer syndromes. Oncologist 2004;9:13-24. [PMID: 14755011 DOI: 10.1634/theoncologist.9-1-13] [Cited by in Crossref: 73] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
302 Robinson S, Cohen AR. Cowden Disease and Lhermitte-Duclos Disease: Characterization of a New Phakomatosis. Neurosurgery 2000;46:371-371. [DOI: 10.1097/00006123-200002000-00021] [Cited by in Crossref: 67] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
303 Zysman MA, Chapman WB, Bapat B. Considerations when analyzing the methylation status of PTEN tumor suppressor gene. Am J Pathol 2002;160:795-800. [PMID: 11891178 DOI: 10.1016/S0002-9440(10)64902-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
304 Tekin M, Hişmi BO, Fitoz S, Yalçinkaya F, Ekim M, Kansu A, Ertem M, Deda G, Tutar E, Arsan S, Zhou XP, Pilarski R, Eng C, Akar N. A germline PTEN mutation with manifestations of prenatal onset and verrucous epidermal nevus. Am J Med Genet A 2006;140:1472-5. [PMID: 16752378 DOI: 10.1002/ajmg.a.31273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
305 Jing J, Wang B, Liu P. The Functional Role of SEC23 in Vesicle Transportation, Autophagy and Cancer. Int J Biol Sci 2019;15:2419-26. [PMID: 31595159 DOI: 10.7150/ijbs.37008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
306 Stathopoulos P, Raymond A, Esson M. Cowden syndrome: mucocutaneous lesions as precursors of internal malignancy. Oral Maxillofac Surg 2014;18:229-35. [PMID: 24687348 DOI: 10.1007/s10006-014-0445-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
307 Gustafson S, Zbuk KM, Scacheri C, Eng C. Cowden syndrome. Semin Oncol 2007;34:428-34. [PMID: 17920899 DOI: 10.1053/j.seminoncol.2007.07.009] [Cited by in Crossref: 102] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
308 Lehrer RI, Nguyen T, Zhao C, Ha CX, Glasgow BJ. Secretory Lipophilins: A Tale of Two Species. Annals of the New York Academy of Sciences 2000;923:59-67. [DOI: 10.1111/j.1749-6632.2000.tb05519.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
309 Palmero EI, Alemar B, Schüler-Faccini L, Hainaut P, Moreira-Filho CA, Ewald IP, Santos PK, Ribeiro PL, Oliveira CB, Calvez-Kelm FL, Tavtigian S, Cossio SL, Giugliani R, Caleffi M, Ashton-Prolla P. Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil. Genet Mol Biol 2016;39:210-22. [PMID: 27223485 DOI: 10.1590/1678-4685-GMB-2014-0363] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
310 Kubo Y, Urano Y, Hida Y, Ikeuchi T, Nomoto M, Kunitomo K, Arase S. A novel PTEN mutation in a Japanese patient with Cowden disease. Br J Dermatol 2000;142:1100-5. [PMID: 10848731 DOI: 10.1046/j.1365-2133.2000.03533.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
311 Rajendran BK, Deng CX. Characterization of potential driver mutations involved in human breast cancer by computational approaches. Oncotarget 2017;8:50252-72. [PMID: 28477017 DOI: 10.18632/oncotarget.17225] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
312 Lima EUD, Soares IC, Danilovic DLS, Marui S. New mutation in the PTEN gene in a Brazilian patient with Cowden's syndrome. Arq Bras Endocrinol Metab 2012;56:592-6. [DOI: 10.1590/s0004-27302012000800022] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
313 Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns. 2009;18:13-27. [PMID: 18972196 DOI: 10.1007/s109897-008-9187-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
314 Haddadi N, Travis G, Nassif NT, Simpson AM, Marsh DJ. Toward Systems Pathology for PTEN Diagnostics. Cold Spring Harb Perspect Med 2020;10:a037127. [PMID: 31615872 DOI: 10.1101/cshperspect.a037127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
315 Murray C, Shipman P, Khangure M, Chakera T, Robbins P, Mcauliffe W, Davis S. Lhermitte-Duclos disease associated with Cowden's syndrome: Case report and literature review. Australas Radiol 2001;45:343-6. [DOI: 10.1046/j.1440-1673.2001.00933.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
316 Uppal S, Mistry D, Coatesworth AP. Cowden disease: a review: Cowden disease. International Journal of Clinical Practice 2007;61:645-52. [DOI: 10.1111/j.1742-1241.2006.00896.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
317 Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet. 1997;16:333-334. [PMID: 9241266 DOI: 10.1038/ng0897-333] [Cited by in Crossref: 423] [Cited by in F6Publishing: 387] [Article Influence: 17.6] [Reference Citation Analysis]
318 Tonin PN. Genes implicated in hereditary breast cancer syndromes. Semin Surg Oncol 2000;18:281-6. [DOI: 10.1002/(sici)1098-2388(200006)18:4<281::aid-ssu2>3.0.co;2-q] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
319 Gosein M, Harris A, Pang E, Maharaj P, Chang S. Abdominal Imaging Findings in Neurocutaneous Syndromes: Looking Below the Diaphragm. American Journal of Roentgenology 2017;209:1197-208. [DOI: 10.2214/ajr.17.18404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
320 Lee DA, Grossman ME, Schneiderman P, Celebi JT. Genetics of skin appendage neoplasms and related syndromes. J Med Genet 2005;42:811-9. [PMID: 16272260 DOI: 10.1136/jmg.2004.025577] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
321 Merg A, Lynch HT, Lynch JF, Howe JR. Hereditary colorectal cancer-part II. Curr Probl Surg 2005;42:267-333. [PMID: 15900295 DOI: 10.1067/j.cpsurg.2005.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
322 Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ, Bos C, Dasouki M, Feldman GL, Greenberg LA, Ivanovich J, Matloff E, Patterson A, Pierpont ME, Russo D, Nassif NT, Eng C. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 2003;73:404-11. [PMID: 12844284 DOI: 10.1086/377109] [Cited by in Crossref: 205] [Cited by in F6Publishing: 151] [Article Influence: 11.4] [Reference Citation Analysis]
323 Patterson AR, Leitch AM, Weatherall P, Zhou X, Eng C, Tomlinson GE. CASE 4. Fibrocystic Breast Disease in a 16-Year-Old Female With PTEN Hamartoma Tumor Syndrome. JCO 2006;24:525-7. [DOI: 10.1200/jco.2004.01.0447] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
324 Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997;16:64-67. [PMID: 9140396 DOI: 10.1038/ng0597-64] [Cited by in Crossref: 1332] [Cited by in F6Publishing: 1175] [Article Influence: 55.5] [Reference Citation Analysis]
325 Mintzer D, Glassburn J, Mason BA, Sataloff D. Breast cancer in the very young patient: a multidisciplinary case presentation. Oncologist 2002;7:547-54. [PMID: 12490742 DOI: 10.1634/theoncologist.7-6-547] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
326 Gray IC, Fallowfield J, Ford S, Nobile C, Volpi EV, Spurr NK. An integrated physical and genetic map spanning chromosome band 10q24. Genomics 1997;43:85-8. [PMID: 9226376 DOI: 10.1006/geno.1997.4809] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
327 Aloraifi F, Boland MR, Green AJ, Geraghty JG. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer. Surg Oncol 2015;24:100-9. [PMID: 25936246 DOI: 10.1016/j.suronc.2015.04.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
328 Çelebi JT, Chen FF, Zhang H, Ping XL, Tsou HC, Peacocke M. Identification of PTEN mutations in five families with Bannayan-Zonana syndrome. Exp Dermatol 1999;8:134-9. [DOI: 10.1111/j.1600-0625.1999.tb00361.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
329 Deichmann M, Thome M, Benner A, Egner U, Hartschuh W, Näher H. PTEN/MMAC1 expression in melanoma resection specimens. Br J Cancer 2002;87:1431-6. [PMID: 12454773 DOI: 10.1038/sj.bjc.6600653] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
330 Ngeow J, Eng C. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol. Methods 2015;77-78:11-9. [PMID: 25461771 DOI: 10.1016/j.ymeth.2014.10.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
331 Greene MH. Genetics of breast cancer. Mayo Clin Proc 1997;72:54-65. [PMID: 9005288 DOI: 10.4065/72.1.54] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 2.8] [Reference Citation Analysis]
332 Chaudhry S, Shirlaw P, Morgan P, Challacombe S. Cowden's syndrome (multiple hamartoma and neoplasia syndrome): diagnostic dilemmas in three cases. Oral Diseases 2000;6:248-52. [DOI: 10.1111/j.1601-0825.2000.tb00121.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
333 Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ, Sapp JC, Alomari A, Ezaki M, Dobyns W, Biesecker LG. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015;167A:287-95. [PMID: 25557259 DOI: 10.1002/ajmg.a.36836] [Cited by in Crossref: 229] [Cited by in F6Publishing: 183] [Article Influence: 32.7] [Reference Citation Analysis]
334 Cao W, Wang X, Li JC. Hereditary breast cancer in the Han Chinese population. J Epidemiol 2013;23:75-84. [PMID: 23318652 DOI: 10.2188/jea.je20120043] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
335 Ball S, Arolker M, Purushotham A. Breast cancer, Cowden disease and PTEN-MATCHS syndrome. European Journal of Surgical Oncology (EJSO) 2001;27:604-6. [DOI: 10.1053/ejso.2001.1121] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
336 Murata J, Tada M, Sawamura Y, Mitsumori K, Abe H, Nagashima K. Dysplastic gangliocytoma (Lhermitte-Duclos disease) associated with Cowden disease: report of a case and review of the literature for the genetic relationship between the two diseases. J Neurooncol 1999;41:129-36. [PMID: 10222433 DOI: 10.1023/a:1006167421100] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
337 Eng C. PTEN: One Gene, Many Syndromes. Hum Mutat 2003;22:183-98. [DOI: 10.1002/humu.10257] [Cited by in Crossref: 587] [Cited by in F6Publishing: 489] [Article Influence: 32.6] [Reference Citation Analysis]
338 Mawrin C. [Hereditary tumor syndromes in neuropathology]. Pathologe 2017;38:186-96. [PMID: 28474160 DOI: 10.1007/s00292-017-0292-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
339 Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010;102:680-91. [PMID: 20427433 DOI: 10.1093/jnci/djq088] [Cited by in Crossref: 313] [Cited by in F6Publishing: 233] [Article Influence: 28.5] [Reference Citation Analysis]
340 Takei J, Tochigi S, Arai M, Tanaka T, Kajiwara I, Hatano K, Ichinose D, Sakamoto H, Hasegawa Y, Ishibashi T, Tani S, Murayama Y. Spinal Extradural Arteriovenous Fistula with Cowden Syndrome: A Case Report and Literature Review Regarding Pathogenesis and Therapeutic Strategy. NMC Case Rep J 2018;5:83-5. [PMID: 30327747 DOI: 10.2176/nmccrj.cr.2018-0018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
341 Hampel H, Peltomaki P. Hereditary colorectal cancer: risk assessment and management: Hereditary colorectal cancer. Clinical Genetics 2000;58:89-97. [DOI: 10.1034/j.1399-0004.2000.580201.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
342 Ali RMM, Mcintosh SA, Savage KI. Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy. Genes Chromosomes Cancer 2021;60:358-72. [DOI: 10.1002/gcc.22921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
343 Chetram MA, Hinton CV. PTEN regulation of ERK1/2 signaling in cancer. J Recept Signal Transduct Res 2012;32:190-5. [PMID: 22737980 DOI: 10.3109/10799893.2012.695798] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
344 Banneau G, Guedj M, MacGrogan G, de Mascarel I, Velasco V, Schiappa R, Bonadona V, David A, Dugast C, Gilbert-Dussardier B, Ingster O, Vabres P, Caux F, de Reynies A, Iggo R, Sevenet N, Bonnet F, Longy M. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations. Breast Cancer Res 2010;12:R63. [PMID: 20712882 DOI: 10.1186/bcr2626] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
345 Zhao C, Nguyen T, Yusifov T, Glasgow BJ, Lehrer RI. Lipophilins: Human Peptides Homologous to Rat Prostatein. Biochemical and Biophysical Research Communications 1999;256:147-55. [DOI: 10.1006/bbrc.1999.0274] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
346 Pezzolesi MG, Li Y, Zhou XP, Pilarski R, Shen L, Eng C. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes. Am J Hum Genet. 2006;79:923-934. [PMID: 17033968 DOI: 10.1086/508943] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
347 Borowsky J, Setia N, Rosty C, Conrad R, Susman R, Misdraji J, Hart J, Lauwers GY, Brown IS. Spectrum of gastrointestinal tract pathology in a multicenter cohort of 43 Cowden syndrome patients. Mod Pathol 2019;32:1814-22. [DOI: 10.1038/s41379-019-0316-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
348 Singh B, Ittmann MM, Krolewski JJ. Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosom Cancer 1998;21:166-71. [DOI: 10.1002/(sici)1098-2264(199802)21:2<166::aid-gcc13>3.0.co;2-p] [Cited by in Crossref: 53] [Article Influence: 2.3] [Reference Citation Analysis]